Navigation Links
Stat Fax 2200

ProductsStat Fax 2200
Company Awareness Technology, Inc.
Item Stat Fax 2200
Features Holds two 96 well microplates. Digital timer controls shaking or can be operated independently as a timer. Compact and easy to operate. Outer tinted cover help to provides further insulation and protection from light. Certified from NRTL and CE.
Description Stat Fax 2200 Incubator shaker.
Info Awareness Technology, Inc.
Customer Service: (772) 283-6540
Web site: http://www.awaretech.com/

Related medicine products :

1. Bellco Personal Microplate Orbis Shaker
2. PVA, The Personal Vision Assistant
3. Pol-O.R. BearPersonal Air Conditioning System
4. T4 Personal Protection System
5. Innova CO-48 Personal-Sized Direct Heat CO2 Incubator, for on-or-under bench
6. Innova U101 Personal-Sized -86°C Upright Freezer, 3.6 cu. ft.
7. PersonalHyb Hybridization Oven, 100/120V
8. PersonalHyb Hybridization Oven, 230V
9. MiniSpin plus Personal Micro Centrifuge
10. MiniSpin Personal Micro Centrifuge
11. MiniSpin plus Special Limited Edition Personal Micro Centrifuge
TAG: Stat Fax
A sophisticated research tool that allows to see the fundus picture of the area which is being stimulated. Besides it also includes the refractive pupil camera enabling the examiner to switch between
The only air-based esthesiometer with a database of normal sensation on the cornea. May have application to the measurement of normal-tension glaucoma.
Kelly Punches
... instrument provides standardized glare testing. I...ces for the evaluation of glare disability. For ca...ecisely calibrated to simulate two on-coming halog...The glare level can be adjusted to simulate other ...
Medicine Products:
(Date:9/7/2008)...s also been linked recently to patient deaths , ...w once-a-week formulation of the injectable diabet...an the older twice-a-day formulation, researchers ..., [the new formulation] provided the remarkable ad...ol and good gastrointestinal tolerability," said D...
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Lieuten...proclamation acknowledging Sept. 11 as,American Re...nsylvania and The American Red Cross ask donors,of... those who lost their,lives on 9/11 and to help st...ion can save up to three lives., "We all remember...
(Date:9/5/2008)...xplain how theoretical ,anti-cloak, could bring ob...(HealthDay News) -- Just in case someone develops ...sts say they know how to uncloak the objects it hi...s Express , certain materials underneath an invisi...een again. , Researchers at Shanghai Jiao Tong ...
(Date:9/5/2008)... Mass., Sept. 5 /PRNewswire/ -- Arthrosurface, Inc...of less-invasive joint,resurfacing systems, announ...A to begin its pivotal investigation for its line ... that "there are no outstanding safety,concerns" w... Arthrosurface has been evaluating the safety and ...
Breaking Medicine News(10 mins):Health News:Once-Weekly Diabetes Drug Boosts Blood Sugar Control 2Health News:Arthrosurface HemiCAP(R) Focal Knee Resurfacing Implant Receives FDA Approval to Move into Final Investigational Stage 2
...urvey suggests that approximately 50% of the publi...t of a bird flu pandemic. // A majority of these p...al support staff. More than 308 public health wor... which nearly 46.2% expressed that they would not ...
...hrough a study by neuroscientists at Harvard Medic...ong-term exposure to stress hormone in mice direct... depression. April issue of Behavioral Neuroscienc...Psychological Association, has this article. This...
...sychological Science says that children's habits a...cially true in determining if a child would be an ...ld as clay to be molded,” said Phillip Dale, profe...nce and Disorders Department in the School of Heal...
...onducted by drug researchers has revealed that ena...inmates who are addicted to heroin, //would serve ...ffence and the cost of locking up prisoners for a ...onal Health and Medical Research Council sponsored...
Other Medicine News:Health News:Bird Flu Pandemic Study: Clerical & Support Staff May Stay At Home 2Health News:Link Between Stress Hormone And Depression Revealed 2Health News:Cost-Benefit Economics of Methadone for prisoners 2
(Date:9/8/2008)...t. 8 /- Medarex, Inc.,(Nasd...estone payment for an,undisclosed amount from its ... payment is a result of the submission of an Inves...r the clinical development of an antibody,generate...receive future,milestone payments and royalties sh...
(Date:9/6/2008)...ety and Efficacy of First-in-Class Neurally Acting...of Acute Migraine, LONDON, Sept. 6 /...technology company focusing on therapies for centr...sults of its lead compound COL-144,in the treatmen...-144 was,safe and effective in relieving migraine ...
(Date:9/5/2008)... Calif., Sept. 5 /- SARcode...olecule LFA-1 inhibitors,to treat inflammatory dis...SNSS) today announced SARcode,s initiation of a Ph...duct candidate for T-cell mediated ophthalmic,dise...greement providing,SARcode with an exclusive licen...
(Date:9/4/2008)...ept. 4 /- BioForm Medical,...otal clinical study of,Polidocanol, conducted in G...rik KREUSSLER & Co. GmbH (Kreussler), successfully...tted to FDA as part of a New Drug Application,(NDA...the EASI (Efficacy and safety of,Aethoxysklerol co...
Breaking Medicine Technology:Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing 2Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing 3Phase II Results of COL-144 Presented at European Headache and Migraine Trust International Congress 2008 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5Pharmasset Appoints Michael Rogers as Chief Development Officer 1664 1Pharmasset Appoints Michael Rogers as Chief Development Officer 1664 2Pharmasset Appoints Michael Rogers as Chief Development Officer 1664 3Renovis to Present at CIBC World Markets Healthcare Conference 1661 1Symmetry Medical to Provide Third Quarter 2007 General Business Update on November 7 2007 1658 1Symmetry Medical to Provide Third Quarter 2007 General Business Update on November 7 2007 1658 2Pharmacopeia Announces Third Quarter 2007 Financial Results 727 1Pharmacopeia Announces Third Quarter 2007 Financial Results 727 2Pharmacopeia Announces Third Quarter 2007 Financial Results 727 3Pharmacopeia Announces Third Quarter 2007 Financial Results 727 4Pharmacopeia Announces Third Quarter 2007 Financial Results 727 5Pharmacopeia Announces Third Quarter 2007 Financial Results 727 6Pharmacopeia Announces Third Quarter 2007 Financial Results 727 7Pharmacopeia Announces Third Quarter 2007 Financial Results 727 8Pharmacopeia Announces Third Quarter 2007 Financial Results 727 9Pharmacopeia Announces Third Quarter 2007 Financial Results 727 10Pharmacopeia Announces Third Quarter 2007 Financial Results 727 11
...wide pivotal phase III study in women with recurre...WASHINGTON, May 01, 2007,/PRNewswire-FirstCall/ --... of action of phenoxodiol, an investigational drug.... The drug appears to,work by targeting a certain ... events that selectively induce cancer cell death....
...GENEVA, Switzerland, May 2, 2007 – Merck,Ser...III data on,safinamide, a new agent in Phase III d...disease symptoms, were presented by Professor,Fabr...59th Annual,Meeting in Boston, Massachusetts, USA....zed, double blind, placebo-controlled,internation...
Other Medicine Technology:New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 2New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 3New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 4New Research Results Show That Investigational Drug Phenoxodiol,Targets Cancer Protein, Causing Cancer Cell Death 5Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 2Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 3Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 4Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 5